30,287 copies distributed monthly – to every rural mailbox in Canterbury and the West Coast
May 2022 Edition
INSIDE
THIS EDITION Piggy in-the-middle
p5 Feed plan B
p10 Plantain research
p20 New log fumigant
p30
Green light: Launching the $32m project near Kaikoura, one of Puro’s premium grow sites, were Carmen Doran (Chief Executive of Helius), Tim aldridge (Managing Director of Puro), Damien O’Connor (Minister of agriculture), and Steve Wilson (Chair of NZ Medicinal Cannabis Council).
Organic medicinal cannabis growing a huge opportunity A partnership between the Government and South Island-based medicinal cannabis grower Puro is aimed at fast-tracking New Zealand’s organic medicinal cannabis industry.
] by Kent Caddick The $32 million partnership programme will run from 2022 to 2027, with the Ministry of Primary Industries’ Sustainable Food and Fibre Futures (SFF Futures) contributing $13 million and Puro the remainder. Puro, the country’s largest and only organic certified medicinal cannabis grower, was founded in 2018, and harvested its first crop of medical cannabis last year. Puro Managing director Tim Aldridge said the grant was a game-changer which will provide New Zealand patients with greater access to locally grown and manufactured
medicine and pave the way for international export success. Under the agreement, Puro will develop production systems, support skills and training, explore contract growing and identify pathways to market for industry growth. “Being one of New Zealand’s first medicinal cannabis companies has meant we’ve had to overcome some major challenges. It hasn’t been easy,” Aldridge said “This programme will see us create an organic production handbook that will be invaluable for Puro and our industry. “The grant will also support Puro in developing post-harvesting processing technology
and build the IP required to produce premium organic cannabis flower to meet increasing domestic and global demand.” He said the funding will enable Puro to develop unique cultivars and seed stock for the New Zealand industry. “Our cultivation team are researching and developing the strains of medicinal cannabis best suited for New Zealand’s unique climate. The grant will see the acceleration of a large genetic database of cultivars to support the New Zealand industry and differentiate our cannabis products in global markets.”
TO PAGE 2